• AZ505: From SMYD2 Inhibition to Causal Biology

  2026-10-07

  AZ505 is a selective SMYD2 inhibitor whose value extends beyond potency measurements. This article examines how its biochemical profile, renal fibrosis evidence, and model limitations inform epigenetic regulation research and future cancer biology studies.

• Resiniferatoxin (RTX) as a TRPV1 Causality Tool

  2026-10-06

  Resiniferatoxin (RTX) is more than an ultra-potent TRPV1 agonist: it can help test whether TRPV1 activity is causally involved in inflammatory disease biology. This article interprets the GERD evidence, clarifies RTX’s mechanistic limits, and outlines research questions beyond conventional analgesia.

• SFRP1, Wnt/β-Catenin, and Oral Fibrosis

  2026-10-06

  A 2024 study links reduced SFRP1 with neutrophil infiltration, collagen accumulation, and canonical Wnt/β-catenin activation in an arecoline-induced mouse model of oral submucous fibrosis. Its combination of tissue correlation, SFRP1 overexpression, and pathway-reactivation experiments supports a mechanistic relationship, while remaining preclinical and model-dependent.

• MOG (35-55): Reading EAE Through IFN-I Biology

  2026-10-05

  MOG (35-55) is a myelin oligodendrocyte glycoprotein peptide that provides an antigen-defined context for autoimmune encephalomyelitis research. This article interprets its value through the 2025 PARP7–STAT1/STAT2 study, emphasizing evidence boundaries, pathway biology, and translational relevance rather than experimental workflow.

• KX2-391 Dihydrochloride: Evidence Overview

  2026-10-05

  KX2-391 dihydrochloride, also called Tirbanibulin dihydrochloride, is discussed as a dual-mechanism Src and tubulin inhibitor with an established topical actinic keratosis context. A 2024 HeLa-cell study supports effects on proliferation, HPV-18 oncoprotein expression, oncogenic signaling, and apoptosis, while evidence for broader HPV, HBV, and BoNT/A applications remains more limited and indication-specific.

• Rice Stripe Virus NS3 and Host Kinase Signaling

  2026-10-04

  Zhuang et al. show that Rice stripe virus NS3 switches between distinct effects on host defense as infection progresses, linking NS3 phosphorylation to the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway. The study provides a mechanistic model for how a plant virus balances pathogenicity, host or vector survival, and transmission rather than maximizing damage at every stage.

• L1023 Anti-Cancer Compound Library: Evidence Overview

  2026-10-03

  A source-grounded overview of the L1023 Anti-Cancer Compound Library, its potential role in cancer research, and the evidence surrounding capsazepine, MCL1 inhibition, and tamoxifen resistance.

• Linoleic Acid (C18:2): Practical Assay Guide

  2026-10-02

  Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a defined lipid input for oxidative stress, membrane, erythrocyte, epithelial migration, and essential fatty acid studies. It is suited to freshly prepared ethanol- or DMSO-based workflows, but not to aqueous-only assays or experiments requiring long-term storage of prepared solutions.

• Capsazepine as an MCL1 Inhibitor in Breast Cancer

  2026-10-01

  The reference study identifies capsazepine as a previously unrecognized MCL1-binding compound that suppresses tamoxifen-resistant breast cancer cells. Through virtual screening, structural modeling, cellular assays, and DARTS-based target validation, the authors connect MCL1 inhibition with mitochondrial apoptosis and renewed tamoxifen sensitivity.

• PRX3 Targeting in Mesothelioma: Preclinical to Phase 1

  2026-10-01

  The reference study connects mitochondrial PRX3 dependence with mesothelioma growth, showing that genetic deletion and thiostrepton-based pharmacological inhibition disrupt tumor redox homeostasis. Its phase 1 findings provide an early clinical rationale for local PRX3 targeting, while SLC7A11 emerges as a candidate mediator of resistance.

• FPH1 (BRD-6125) Hepatocyte Assay Guide

  2026-09-30

  This scenario-based guide explains how FPH1 (BRD-6125) Hepatocyte Functional Proliferation Enhancer, SKU B3701, can help researchers distinguish hepatocyte expansion from functional maturation. It covers assay design, dosing, solubility, orthogonal readouts, and practical vendor-selection criteria for primary and iPS-derived hepatocyte workflows.

• Cell Counting Kit-8 (CCK-8) for Reliable Assays

  2026-09-30

  This scenario-driven guide explains how Cell Counting Kit-8 (CCK-8), SKU K1018, supports reproducible cell viability, proliferation, and cytotoxicity measurements. It covers WST-8 chemistry, controls, optimization, interpretation, and practical vendor-selection criteria for biomedical research.

• Protease Inhibitor Cocktail for Liver Protein Workflows

  2026-09-29

  Protect liver and macrophage proteins during disruption with an EDTA-free, broad-spectrum formulation suited to Western blotting, co-immunoprecipitation, kinase assays, and other cation-sensitive workflows. This guide connects practical sample handling with the macrophage and inflammasome findings reported in a Mallory-Denk body model.

• 2,7-Dichlorodihydrofluorescein diacetate ROS Workflow

  2026-09-29

  Build a practical DCFH-DA workflow for fluorescence microscopy, flow cytometry, and plate-based oxidative stress assays. The guide connects intracellular ROS measurement with the THBS1/PI3K/AKT findings in granulosa-cell research while emphasizing controls, normalization, and probe-specific limitations.

• Angiotensin I: From Precursor to Translation

  2026-09-28

  Angiotensin I is more than an intermediate in the renin-angiotensin system. As a defined ACE substrate, it enables researchers to separate peptide conversion from downstream receptor signaling and build more interpretable cardiovascular, neuroendocrine, and antihypertensive drug studies.

8436 records 1/563 page Next 12345 下5页 Last page